Leflunomide (Arava™) is a useful DMARD in Indian (Asian) patients: a clinic-based observational study of 1-year treatment-Reference-Cited by-同舟云学术

Leflunomide (Arava™) is a useful DMARD in Indian (Asian) patients: a clinic-based observational study of 1-year treatment

Published:2008-05-10 Issue:8 Volume:27 Page:1039-1044
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Chopra Arvind,Saluja Manjit,Lagu-Joshi Vaijayanti,Sarmukadam Sanjiv

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-008-0897-x.pdf

Reference25 articles.

1. Smolen JS, Kalden JR, Scott DL et al (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomized, multicentre trial. Lancet 353:259–266

2. Strand V, Cohen S, Schiff M et al (1999) Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 159:2542–2550

3. Cohen S, Cannon GW, Schiff M et al (2001) For the Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Two year, blinded, randomized controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis Rheum 44(9):1984–92

4. Kalden JR, Schattenkirchner M, Soresen H et al (2003) The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five year follow up study. Arthritis Rheum 48:1513–1520

5. Osiri M, Beverley S, Robinson V et al (2003) Leflunomide for the treatment of rheumatoid arthritis: a systematic review and met analysis. J Rheumatol 30:1182–1190

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of the Methotrexate–leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil);The Journal of Rheumatology;2021-05-01

2. Quality of life and clinical outcomes in Polish patients with high activity rheumatoid arthritis treated with leflunomide (Arava®) in Therapeutic Program: A retrospective analysis of data from the PLUS study;Advances in Clinical and Experimental Medicine;2019-10-29

3. Leflunomide-induced liver injury in mice: Involvement of TLR4 mediated activation of PI3K/mTOR/NFκB pathway;Life Sciences;2019-10

4. Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach;Therapeutic Advances in Musculoskeletal Disease;2016-08-20

5. Leflunomide in Pakistani patients with rheumatoid arthritis: prospective study in daily rheumatology practice;International Journal of Rheumatic Diseases;2011-02